Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Cardiol. 2010 Nov 19;145(2):326-8. doi: 10.1016/j.ijcard.2009.11.051. Epub 2010 Jan 19.

Midregional pro-A-type natriuretic peptide for the evaluation of exercise intolerance.

Abstract

The aim of this study was to determine the accuracy of midregional pro-A-type natriuretic peptide (MR-proANP) for the identification of a cardiocirculatory exercise limitation (CL) as assessed by cardiopulmonary exercise testing (CPET) and to compare it to B-type natriuretic peptide (BNP). Among 94 patients with CPET data fulfilling criteria for appropriate effort and sufficient diagnostic certainty, 27 (29%) had CL. The areas under the receiver-operator-characteristic curve for MR-proANP and BNP to identify CL were 0.84 and 0.79 respectively (p=0.17). In conclusion, MR-proANP had a comparable accuracy to BNP for the identification of CL and might be a valuable assistance for the differentiation of exercise intolerance.

PMID:
20034689
DOI:
10.1016/j.ijcard.2009.11.051
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center